---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294414901.md"
description: "Fulgent Genetics shares are trading lower after the company reported worse-than-expected Q2 financial results and lowered its FY2026 adjusted EPS and FY2026 sales guidance."
datetime: "2026-07-30T20:51:55.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294414901.md)
  - [en](https://longbridge.com/en/news/294414901.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294414901.md)
generator: "portal-rs"
---

# 

Fulgent Genetics shares are trading lower after the company reported worse-than-expected Q2 financial results and lowered its FY2026 adjusted EPS and FY2026 sales guidance.

### Related Stocks

- [FLGT.US](https://longbridge.com/en/quote/FLGT.US.md)

## Related News & Research

- [Fulgent Genetics Q2 revenue rises 20% sequentially, sees billing system transition delay](https://longbridge.com/en/news/294410077.md)
- [BUZZ-Street View: Argon revives Google's AI standing, but questions remain](https://longbridge.com/en/news/300699265.md)
- [Netflix CEO Says Company’s Growth Not Good Enough: ‘Working on Making that Move Faster’](https://longbridge.com/en/news/300705564.md)
- [Google Stock Gets $420 Price Target from BNP Paribas – Here's Why](https://longbridge.com/en/news/300731266.md)
- [Why Did Google Stock Gain in After-Hours Trading on Wednesday?](https://longbridge.com/en/news/300646068.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**